TrialJournal of the National Cancer Institute2021

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS).

Henrik Olsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.